Retrospective analysis of the safety of Herceptin immunotherapy in metastatic breast cancer.
about
Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.A human monoclonal autoantibody to breast cancer identifies the PDZ domain containing protein GIPC1 as a novel breast cancer-associated antigen.New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management.Severe infusion reactions to cetuximab occur within 1 h in patients with metastatic colorectal cancer: results of a nationwide, multicenter, prospective registry study of 2126 patients in Japan.Anaphylaxis: mechanisms and management.A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors.Delayed Paclitaxel-trastuzumab-induced interstitial pneumonitis in breast cancer.Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesisPulmonary toxicity from novel antineoplastic agents.A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients.Evaluation of IgE Antibodies to Omalizumab (Xolair®) and Their Potential Correlation to AnaphylaxisTrastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise.Transtuzumab induced organizing pneumonia: a case report.Incidence, risk factors, and management of infusion-related reactions in breast cancer patients receiving trastuzumab.Toxicoproteomics: new paradigms in toxicology research.Safety profile of new anticancer drugs.Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies.Pneumonitis and pulmonary fibrosis associated with breast cancer treatments.Management of pulmonary toxicity associated with targeted anticancer therapies.Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies.Monoclonal antibodies: formulations of marketed products and recent advances in novel delivery system.A phase I dose-escalation and bioequivalence study of a trastuzumab biosimilar in healthy male volunteers.[Pulmonary complications in chemotherapy].Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?Immunogenicity issues in drug development.Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study.
P2860
Q30441575-7FF3DCB6-8F0F-4931-854F-0E4002B012C3Q33362597-A4245CA4-7340-495C-B3F7-3D01F26E2BABQ33564645-C74428B0-3824-4B6A-BB43-FB120B94312FQ33662080-0C0CBA92-833A-4357-8F05-6F39D91B8475Q34192100-20D9D4B9-C434-41D0-906C-B58E8A5773C9Q34403364-DF155F49-94B4-4FC8-BFB3-613A05B4D4D0Q34832259-CB587196-190F-44E4-A9BC-DED7DC6256DFQ35584206-2590609A-04BD-48D4-8550-1EDC0095F884Q36007575-6CCF0298-1A72-4F0E-B637-B3572B88BBD9Q36314452-01D5AC66-B461-4D18-BDC3-E407EAC31F38Q36396272-C2ECF6ED-1F25-49DE-AA0E-E190B7B9DF68Q36445108-17EF063B-DE49-4242-A557-2C53082F0184Q37378906-8E70D3C5-A9B2-4076-8F2A-906F0DEF041EQ37413374-19EDF6D4-CE08-4910-903C-CA6B3F7FB00FQ37644531-D2C94354-7C89-4E0A-89B8-F6BAB48B50F8Q37696489-5EC1E38D-D334-42BA-B329-70B3FDCBB41DQ37696502-3D140F97-F500-4C14-9B68-3EECB5C6309DQ37965600-B2A34D18-4457-462A-B63E-18ECD8AB2E6EQ38220276-F3484614-B521-4191-86F9-18AEB7CA5D94Q38570532-2CA936BD-FD66-4128-8C13-267EEC71010EQ38859163-5A7655B9-3280-4540-BAC9-A9270A9F1C0CQ39066090-966E9893-CA6F-4B44-805C-1965F5F479B8Q40183869-E6E9AE99-3013-4130-AEF0-67F6919A2451Q41701062-F8660140-A146-4B24-AD41-5FC0FB6B0229Q41771261-7EAD8977-04A9-4F7E-AD97-33445487D0B7Q46717338-E8F4D109-0E03-4877-AF4A-614FA64823A9Q54593797-364FAF5A-1C4D-4C80-8578-8782CD204850
P2860
Retrospective analysis of the safety of Herceptin immunotherapy in metastatic breast cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Retrospective analysis of the ...... y in metastatic breast cancer.
@ast
Retrospective analysis of the ...... y in metastatic breast cancer.
@en
Retrospective analysis of the ...... y in metastatic breast cancer.
@nl
type
label
Retrospective analysis of the ...... y in metastatic breast cancer.
@ast
Retrospective analysis of the ...... y in metastatic breast cancer.
@en
Retrospective analysis of the ...... y in metastatic breast cancer.
@nl
prefLabel
Retrospective analysis of the ...... y in metastatic breast cancer.
@ast
Retrospective analysis of the ...... y in metastatic breast cancer.
@en
Retrospective analysis of the ...... y in metastatic breast cancer.
@nl
P356
P1433
P1476
Retrospective analysis of the ...... y in metastatic breast cancer.
@en
P2093
N Cook-Bruns
P356
10.1159/000055403
P478
61 Suppl 2
P577
2001-01-01T00:00:00Z